Matthew B McDougal

6PUBLICATIONS
25CO-AUTHORS
Aerospace structuresMedical virologyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 01, 2026
Pathogenic mutations in ATAD3A cause dysregulation of RagC/D-TFEB axis and disrupt lysosomal homeostasis.

|Oct 22, 2025
IFIT1 is rapidly evolving and exhibits disparate antiviral activities across 11 mammalian orders.

Matthew B McDougal, Ian N Boys, Anthony M De Maria

|Jul 27, 2023
Interferon inhibits a model RNA virus via a limited set of inducible effector genes.

Matthew B McDougal, Anthony M De Maria, Maikke B Ohlson

|Jul 25, 2020
LY6E impairs coronavirus fusion and confers immune control of viral disease.

Stephanie Pfaender, Katrina B Mar, Eleftherios Michailidis

|Sep 19, 2018
A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication.

R Blake Richardson, Maikke B Ohlson, Jennifer L Eitson

|Sep 08, 2018
LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step.

Katrina B Mar, Nicholas R Rinkenberger, Ian N Boys

Pageof 1

Frequent Collaborators

5 joint publications

John W Schoggins

4 joint publications

Ian N Boys

3 joint publications

Katrina B Mar

2 joint publications

Chao Xing